This was posted on BAL by Patience to Win - worth while reading
Chinese Infant Formula Tests Positive for Pathogenic Bacteria | ChemLinked
Chinese Infant Formula Tests Positive for Pathogenic Bacteria
- 13 Mar 2019
- Yilia Ye
- 1030 Views
- Post a comment
Takehome:
On Mar. 7, 2019, China SAMR announced the domestic sampling inspection result of 2936 batches of food products. 2 batches of infant formula foodfailed the inspection [1].
- 2 batches of registered Chinese infant formula milk powder failed sampling inspection conducted by SAMR. One batch tested positive for enterobacter sakazakii.
A batch of “Meijia” infant formula milk powder (stage 1) manufactured by Heilongjiang Nongken Yingbohuawei Dairy Co.,Ltd. tested positive for enterobacter sakazakii. This pathogen is associated with adverse outcomes in neonates, preterm neonates and immunocompromised infants and can cause sepsis, meningitis and necrotizing enterocolitis. GB 10765-2010 stipulates enterobacter sakazakii cannot be detected in infant formula food targeted at infants of 0-6 months.
China’s government has zero tolerance on infant formula which tests positive for enterobacter sakazakii. On May 12, 2016, a batch of Holle organic milk powder produced by Agrana Strke GmbH (Austria) was found to contain enterobacter sakazakii[2]. Its CNCA qualification was immediately suspended 4 days later, and this enterprise was removed from CNCA approval list on Jan. 1st, 2019.
Additionally, “Jingjia Baby” infant formula milk powder (stage 1) produced by Jiangxi Renzhichu Dairy Nutrition Limited was tested to have a chlorine concentration below the minimum stipulated concentration specified in the standard. Inadequate addition as well as loss during production and transportation are the leading factors for nutrient content non-
- Forums
- ASX - By Stock
- A2M
- Media Updates
Media Updates, page-1544
-
- There are more pages in this discussion • 13,156 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$5.59 |
Change
-0.060(1.06%) |
Mkt cap ! $4.041B |
Open | High | Low | Value | Volume |
$5.67 | $5.68 | $5.58 | $14.79M | 2.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 38098 | $5.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.62 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 29294 | 5.580 |
1 | 3788 | 5.570 |
2 | 3656 | 5.560 |
8 | 10076 | 5.550 |
2 | 4500 | 5.520 |
Price($) | Vol. | No. |
---|---|---|
5.620 | 2000 | 1 |
5.640 | 479 | 1 |
5.650 | 7500 | 2 |
5.670 | 3039 | 1 |
5.700 | 19251 | 4 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online